Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  N NERVOUS SYSTEM
    N06 PSYCHOANALEPTICS
      N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
        N06BA Centrally acting sympathomimetics
          N06BA07 Modafinil
            D01832  Modafinil (JAN/USP/INN) <JP/US>

USP drug classification [BR:br08302]
  Sleep Disorder Agents
    Wakefulness Promoting Agents
      Modafinil
        D01832  Modafinil (JAN/USP/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    11  Agents affecting central nervous system
      117  Psychotropics
        1179  Others
          D01832  Modafinil (JAN/USP/INN)

Drug groups [BR:br08330]
  Neuropsychiatric agent
    DG01971  Agents for narcolepsy
      D01832  Modafinil
  Metabolizing enzyme substrate
    DG01633  CYP3A/CYP3A4 substrate
      DG02913  CYP3A4 substrate
        D01832  Modafinil
  Metabolizing enzyme inhibitor
    DG01643  CYP2C9 inhibitor
      D01832  Modafinil
    DG01933  CYP2C19 inhibitor
      D01832  Modafinil
  Metabolizing enzyme inducer
    DG01637  CYP1A2 inducer
      D01832  Modafinil
    DG02891  CYP2B6 inducer
      D01832  Modafinil
    DG02853  CYP3A/CYP3A4 inducer
      DG01635  CYP3A4 inducer
        D01832  Modafinil

New drug approvals in Japan [br08318.html]
  D01832

Drug metabolizing enzymes and transporters [br08309.html]
  D01832

Pharmacogenomic biomarkers [br08341.html]
  D01832

Narcotics and psychotropics in Japan [br08308.html]
  D01832